ARHGDIB Antikörper (AA 66-201)
Kurzübersicht für ARHGDIB Antikörper (AA 66-201) (ABIN7571155)
Target
Alle ARHGDIB Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 66-201
-
Verwendungszweck
- Anti-Human ARHGDIB Polyclonal Antibody
-
Aufreinigung
- Antigen affinity purification.
-
Immunogen
- E. coli - derived recombinant Human ARHGDIB (Asn66-Glu201).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C,-80 °C
-
Informationen zur Lagerung
- Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
-
-
- ARHGDIB (rho GDP Dissociation Inhibitor (GDI) beta (ARHGDIB))
-
Andere Bezeichnung
- ARHGDIB
-
Hintergrund
- ARHGDIB, Rho-GDI beta, Rho GDP-dissociation inhibitor 2, RAP1GN1, Rho GDI 2, GDIA2, GDID4, Ly-GDI
-
UniProt
- P52566
-
Pathways
- Caspase Kaskade in der Apoptose
Target
-